| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| HOXC@ |
|
homeobox C cluster
|
|
|
0.695 |
0.462 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PDB1 |
|
Paget disease of bone 1
|
|
|
0.705 |
0.538 |
| PKD3 |
|
polycystic kidney disease 3 (autosomal dominant)
|
|
|
0.760 |
0.308 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| MLRL |
|
Myeloid leukemia-related gene (myeloid tumor suppressor)
|
|
|
0.564 |
0.769 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| PTENP1 |
|
phosphatase and tensin homolog pseudogene 1
|
|
|
0.650 |
0.577 |
| TDGF1P6 |
|
teratocarcinoma-derived growth factor 1 pseudogene 6
|
|
|
0.659 |
0.577 |
| SNHG1 |
|
small nucleolar RNA host gene 1
|
|
|
0.576 |
0.692 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| PCA3 |
|
prostate cancer associated 3
|
|
|
0.663 |
0.615 |